Your doctor will determine the best dosage to suit your needs. The typical dosage for immediate-release Cipro is 250–750 mg every 12 hours for up to 14 days. Your doctor will determine the best form and dosage of Cipro for your condition. Typical dosage: 250–500 mg every 12 hours for 3 to 14 days.
Antibiotics should not be used as a first-line treatment for bronchitis. If your practitioner does decide to treat your cough with antibiotics, they’re likely to prescribe: 4 Fluoroquinolones like Cipro (ciprofloxacin) and Levaquin (levofloxacin)
Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days. The short-term response rate was 97% (cure 70.6%, improvement 26.4%) and failure 3%; the long-term response rate (six months follow-up) was 73.5%.
Most of these side effects may go away within a few days or a couple of weeks. If they’re more severe or don’t go away, talk to your doctor or pharmacist. This is not common, but in some cases, Cipro can cause more serious side effects. Call your doctor right away if you have any serious side effects.
I get UTI's often, my doctor usually gives me cipro for 7-10 days. I had a scrip for 20 and I took 2 a day for 5 days and about 3 weeks later I developed another. I was wondering if I should take the whole scrip which would be 10 days as you suggest. Is it possible I did not kill the germ with only 5 days of meds?
Ciprofloxacin may also be used to treat bronchitis, sinus infections, or urinary tract infections but should not be used for bronchitis and sinus infections, or certain types of urinary tract infections if there are other treatment options.
Adults—250 to 500 milligrams (mg) 2 times a day, taken every 12 hours for 7 to 14 days. Children—Dose is based on body weight and must be determined by your doctor. The dose is usually 10 to 20 milligrams (mg) per kilogram (kg) of body weight every 12 hours for 10 to 21 days.
Whenever you're prescribed antibiotics, you need to take the full course of drugs, anywhere from seven to 14 days. You need to continue taking them even if you start feeling better before the course is done.
The study results support the clinical efficacy of ciprofloxacin in the outpatient management of lower and upper respiratory tract infections. In addition, the safety of ciprofloxacin in general medical practice was substantiated.
Because of the availability of other oral and effective agents, ciprofloxacin is not recommended for empirical treatment of community acquired lower respiratory infections, but should be reserved for infections caused by multiply resistant organisms.
Ciprofloxacin can be safely taken at higher oral doses (above 500 mg twice a day) as a long-term therapy and thus different dosage options can be considered [30]. Therefore, the possible dual-mode of action could be especially used in the broad range of anti-infective activities in patients with COVID-19.
Doxycycline and amoxicillin are a couple examples of antibiotics used to treat bronchitis. Macrolide antibiotics such as azithromycin are used for less common cases of bronchitis caused by pertussis (whooping cough). Side effects of antibiotics may include nausea, vomiting, diarrhea, or mild skin rash.
Amoxicillin is the preferred treatment in patients with acute bacterial rhinosinusitis. Short-course antibiotic therapy (median of five days' duration) is as effective as longer-course treatment (median of 10 days' duration) in patients with acute, uncomplicated bacterial rhinosinusitis.
Antibiotics are drugs that kill or prevent the growth of bacteria. Acute bronchitis is usually caused by viruses, though, so antibiotics won't help.
However, ciprofloxacin is inappropriate initial therapy for common outpatient infections, including otitis media, sinusitis, pharyngitis, and pneumonia.
Although ciprofloxacin starts working within hours of taking it, you may not notice an improvement in your symptoms for 2 to 3 days. For some infections, such as osteomyelitis (a bone infection), it may take up to a week before you show any improvement.
However, ciprofloxacin exhibits poor activity against Streptococcus pneumoniae, a major cause of community-acquired respiratory tract infections, thus limiting its use for empiric therapy for these indications.